YADONG GROUP (01795) announced its interim results, with a profit attributable to shareholders of 26.4 million yuan, an increase of 33.35% compared to the same period last year.

20:24 28/08/2026

Yadong Group (01795) announced its performance for the six months ended June 30, 2026. During this period, the group achieved revenue of RMB 605 million, an increase of 23.7% year-on-year; profit attributable to the companys owners was RMB 26.4 million, an increase of 33.35% year-on-year; basic earnings per share were 4.4 cents.

YADONG GROUP (01795) announced its results for the six months ending June 30, 2026, during which the group achieved revenue of 605 million RMB, an increase of 23.7% year-on-year; the profit attributable to company owners was 26.4 million RMB, reflecting a year-on-year increase of 33.35%; and the basic earnings per share were 4.4 cents.

ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.

CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.

TOUYUN BIOTECH (01332) announced its interim performance, with a profit attributed to shareholders of approximately HKD 198 million, representing a year-on-year increase of about 16.6 times.

ABBISKO-B (02256) spent HKD 290,700 on August 28 to repurchase 30,000 shares.

CHINA WANTIAN (01854) announced its interim results, reporting a loss attributable to shareholders of HKD 29.01 million, a year-on-year decrease of 37.96%.

TOUYUN BIOTECH (01332) announced its interim performance, with a profit attributed to shareholders of approximately HKD 198 million, representing a year-on-year increase of about 16.6 times.